Home › Companies › Collegium Pharmaceutical, Inc. › 2025-2026

Collegium Pharmaceutical, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Collegium Pharmaceutical, Inc.’s Form 8-K, filed May 15, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.

  • 18Reported items
  • 333Asset managers
  • 3,605Fund votes
  • May 14, 2026Meeting date

Results at a glance

Meeting of May 14, 2026: 10 items on Collegium Pharmaceutical, Inc.’s Form 8-K, filed May 15, 2026: 7 elected · 2 approved · 1 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Collegium Pharmaceutical, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Collegium Pharmaceutical, Inc.

These tallies are Collegium Pharmaceutical, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 15, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Collegium Pharmaceutical, Inc. — official shareholder meeting results, meeting held May 14, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Rita Balice-Gordon 25,890,2381,343,456186,467 --1,790,765 95%Not verified—
Elect Director: Garen Bohlin 27,093,924243,64982,588 --1,790,765 99.1%Elected—
Elect Director: Michael Donovan 27,383,19435,5191,448 --1,790,765 99.8%Elected—
Elect Director: John Freund, M.D. 26,907,371510,6012,189 --1,790,765 98%Elected—
Elect Director: Vikram Karnani 27,243,959173,8632,339 --1,790,765 99.3%Elected—
Elect Director: Nancy Lurker 27,379,67739,738746 --1,790,765 99.8%Elected—
Elect Director: Carlos Paya, M.D., Ph.D. 26,695,542710,80913,810 --1,790,765 97%Elected—
Elect Director: Gino Santini 26,824,258593,7142,189 --1,790,765 98%Elected—
2. Approval of, on an advisory basis, the compensation of the Company's named executive officers 26,313,7921,100,7235,646 --1,790,765 96%Approved—
3. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 28,953,181252,8154,930 --0 99.1%Approved—

Source: Collegium Pharmaceutical, Inc., Form 8-K, filed with the SEC on May 15, 2026 — read the filing on EDGAR.

How asset managers voted at the Collegium Pharmaceutical, Inc. 2025-2026 meeting

Each item below shows how the 333 asset managers that disclosed a Collegium Pharmaceutical, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Collegium Pharmaceutical, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D…: Carlos Paya, M.D., Ph.D.

No official matchDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

98% of fund votes cast · no official result

FOR
Details: description as filed, votes by 89 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Carlos Paya, M.D., Ph.D.

The 89 asset managers below reported 13,922,762 for, 280,904 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 13,922,762AGAINST: 280,904
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy” at Collegium Pharmaceutical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock2,442,9090 00For
Vanguard2,084,9060 00For
Capitol Series Trust1,430,7080 00For
MFS1,196,5830 00For
Invesco1,064,0250 00For
Fidelity802,5870 00For
State Street647,9910 00For
Principal618,8380 00For
American Century437,7680 00For
Royce267,3830 00For
Victory Capital262,4020 00For
Pacer Funds Trust256,3650 00For
RBB FUND, INC.207,3190 00For
Dimensional204,5660 00For
Bridge Builder Trust171,8000 00For
World Funds Trust165,2080 00For
Janus Detroit Street Trust161,1180 00For
THIRD AVENUE TRUST154,8240 00For
Empower0136,508 00Against
OLD WESTBURY FUNDS INC97,6550 00For
MassMutual81,4000 00For
Loomis Sayles078,552 00Against
AMERICAN BEACON FUNDS75,8800 00For
Brighthouse11,49963,167 00Mixed
Equitable74,2890 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

2. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani…: Garen Bohlin

No official matchDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.8% of fund votes cast · no official result

FOR
Details: description as filed, votes by 89 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Garen Bohlin

The 89 asset managers below reported 14,188,645 for, 15,021 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 14,188,645AGAINST: 15,021
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy” at Collegium Pharmaceutical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock2,442,9090 00For
Vanguard2,084,9060 00For
Capitol Series Trust1,430,7080 00For
MFS1,196,5830 00For
Invesco1,064,0250 00For
Fidelity802,5870 00For
State Street647,92566 00For
Principal618,8380 00For
American Century437,7680 00For
Royce267,3830 00For
Victory Capital262,4020 00For
Pacer Funds Trust256,3650 00For
RBB FUND, INC.207,3190 00For
Dimensional204,5660 00For
Bridge Builder Trust171,8000 00For
World Funds Trust165,2080 00For
Janus Detroit Street Trust161,1180 00For
THIRD AVENUE TRUST154,8240 00For
Empower136,5080 00For
OLD WESTBURY FUNDS INC97,6550 00For
MassMutual81,4000 00For
Loomis Sayles78,5520 00For
AMERICAN BEACON FUNDS75,8800 00For
Brighthouse74,6660 00For
Equitable74,2890 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

3. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani…: Gino Santini

No official matchDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.8% of fund votes cast · no official result

FOR
Details: description as filed, votes by 89 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Gino Santini

The 89 asset managers below reported 14,185,942 for, 17,724 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 14,185,942AGAINST: 17,724
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy” at Collegium Pharmaceutical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock2,442,9090 00For
Vanguard2,084,9060 00For
Capitol Series Trust1,430,7080 00For
MFS1,196,5830 00For
Invesco1,064,0250 00For
Fidelity802,5870 00For
State Street647,92566 00For
Principal618,8380 00For
American Century437,7680 00For
Royce267,3830 00For
Victory Capital262,4020 00For
Pacer Funds Trust256,3650 00For
RBB FUND, INC.207,3190 00For
Dimensional204,5660 00For
Bridge Builder Trust171,8000 00For
World Funds Trust165,2080 00For
Janus Detroit Street Trust161,1180 00For
THIRD AVENUE TRUST154,8240 00For
Empower136,5080 00For
OLD WESTBURY FUNDS INC97,6550 00For
MassMutual81,4000 00For
Loomis Sayles78,5520 00For
AMERICAN BEACON FUNDS75,8800 00For
Brighthouse74,6660 00For
Equitable74,2890 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

4. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram…: John Freund, M.D.

No official matchDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.8% of fund votes cast · no official result

FOR
Details: description as filed, votes by 89 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: John Freund, M.D.

The 89 asset managers below reported 14,188,645 for, 15,021 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 14,188,645AGAINST: 15,021
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy” at Collegium Pharmaceutical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock2,442,9090 00For
Vanguard2,084,9060 00For
Capitol Series Trust1,430,7080 00For
MFS1,196,5830 00For
Invesco1,064,0250 00For
Fidelity802,5870 00For
State Street647,92566 00For
Principal618,8380 00For
American Century437,7680 00For
Royce267,3830 00For
Victory Capital262,4020 00For
Pacer Funds Trust256,3650 00For
RBB FUND, INC.207,3190 00For
Dimensional204,5660 00For
Bridge Builder Trust171,8000 00For
World Funds Trust165,2080 00For
Janus Detroit Street Trust161,1180 00For
THIRD AVENUE TRUST154,8240 00For
Empower136,5080 00For
OLD WESTBURY FUNDS INC97,6550 00For
MassMutual81,4000 00For
Loomis Sayles78,5520 00For
AMERICAN BEACON FUNDS75,8800 00For
Brighthouse74,6660 00For
Equitable74,2890 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

5. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram…: Michael Donovan

No official matchDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 89 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Michael Donovan

The 89 asset managers below reported 14,203,666 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 14,203,666
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy” at Collegium Pharmaceutical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock2,442,9090 00For
Vanguard2,084,9060 00For
Capitol Series Trust1,430,7080 00For
MFS1,196,5830 00For
Invesco1,064,0250 00For
Fidelity802,5870 00For
State Street647,9910 00For
Principal618,8380 00For
American Century437,7680 00For
Royce267,3830 00For
Victory Capital262,4020 00For
Pacer Funds Trust256,3650 00For
RBB FUND, INC.207,3190 00For
Dimensional204,5660 00For
Bridge Builder Trust171,8000 00For
World Funds Trust165,2080 00For
Janus Detroit Street Trust161,1180 00For
THIRD AVENUE TRUST154,8240 00For
Empower136,5080 00For
OLD WESTBURY FUNDS INC97,6550 00For
MassMutual81,4000 00For
Loomis Sayles78,5520 00For
AMERICAN BEACON FUNDS75,8800 00For
Brighthouse74,6660 00For
Equitable74,2890 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

6. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani…: Nancy Lurker

No official matchDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 89 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Nancy Lurker

The 89 asset managers below reported 14,203,666 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 14,203,666
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy” at Collegium Pharmaceutical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock2,442,9090 00For
Vanguard2,084,9060 00For
Capitol Series Trust1,430,7080 00For
MFS1,196,5830 00For
Invesco1,064,0250 00For
Fidelity802,5870 00For
State Street647,9910 00For
Principal618,8380 00For
American Century437,7680 00For
Royce267,3830 00For
Victory Capital262,4020 00For
Pacer Funds Trust256,3650 00For
RBB FUND, INC.207,3190 00For
Dimensional204,5660 00For
Bridge Builder Trust171,8000 00For
World Funds Trust165,2080 00For
Janus Detroit Street Trust161,1180 00For
THIRD AVENUE TRUST154,8240 00For
Empower136,5080 00For
OLD WESTBURY FUNDS INC97,6550 00For
MassMutual81,4000 00For
Loomis Sayles78,5520 00For
AMERICAN BEACON FUNDS75,8800 00For
Brighthouse74,6660 00For
Equitable74,2890 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

7. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D…: Rita Balice-Gordon, Ph.D.

No official matchDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

98% of fund votes cast · no official result

FOR
Details: description as filed, votes by 89 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Rita Balice-Gordon, Ph.D.

The 89 asset managers below reported 13,873,856 for, 281,091 against, 48,719 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 13,873,856AGAINST: 281,091ABSTAIN: 48,719
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy” at Collegium Pharmaceutical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock2,442,9090 00For
Vanguard2,084,9060 00For
Capitol Series Trust1,430,7080 00For
MFS1,196,5830 00For
Invesco1,064,0250 00For
Fidelity802,5870 00For
State Street647,9910 00For
Principal618,8380 00For
American Century437,7680 00For
Royce267,3830 00For
Victory Capital262,4020 00For
Pacer Funds Trust256,3650 00For
RBB FUND, INC.207,3190 00For
Dimensional204,5660 00For
Bridge Builder Trust171,8000 00For
World Funds Trust165,2080 00For
Janus Detroit Street Trust161,1180 00For
THIRD AVENUE TRUST154,8240 00For
Empower0136,508 00Against
OLD WESTBURY FUNDS INC97,6550 00For
MassMutual81,4000 00For
Loomis Sayles078,552 00Against
AMERICAN BEACON FUNDS75,8800 00For
Brighthouse11,49963,167 00Mixed
Equitable74,2890 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

8. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram…: Vikram Karnani

No official matchDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 89 asset managers

Description as filed by funds: Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Vikram Karnani

The 89 asset managers below reported 14,203,600 for, 66 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 14,203,600AGAINST: 66
Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy” at Collegium Pharmaceutical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock2,442,9090 00For
Vanguard2,084,9060 00For
Capitol Series Trust1,430,7080 00For
MFS1,196,5830 00For
Invesco1,064,0250 00For
Fidelity802,5870 00For
State Street647,92566 00For
Principal618,8380 00For
American Century437,7680 00For
Royce267,3830 00For
Victory Capital262,4020 00For
Pacer Funds Trust256,3650 00For
RBB FUND, INC.207,3190 00For
Dimensional204,5660 00For
Bridge Builder Trust171,8000 00For
World Funds Trust165,2080 00For
Janus Detroit Street Trust161,1180 00For
THIRD AVENUE TRUST154,8240 00For
Empower136,5080 00For
OLD WESTBURY FUNDS INC97,6550 00For
MassMutual81,4000 00For
Loomis Sayles78,5520 00For
AMERICAN BEACON FUNDS75,8800 00For
Brighthouse74,6660 00For
Equitable74,2890 00For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

9. Elect Director: Carlos Paya, M.D., Ph.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 26,695,542AGAINST: 710,809
Details: description as filed, official tally, votes by 24 asset managers

Description as filed by funds: Election of directors to hold office until the 2027 Annual Meeting: Carlos Paya, M.D., Ph.D.

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Carlos Paya, M.D., Ph.D.”): 26,695,542 for, 710,809 against, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, Michael Donovan, John Freund, Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini was elected by the Company's shareholders as Directors to hold office until the 2027 Annual Meeting of Shareholders.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 24 asset managers below reported 2,521,849 for, 3 against.

FOR
FOR: 2,521,849AGAINST: 3
Largest asset managers voting on “Election of directors to hold office until the 2027 Annual Meeting: Carlos Paya, M.D., Ph.D.” at Collegium Pharmaceutical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST1,408,0350 00For
Charles Schwab437,9570 00For
HUSSMAN INVESTMENT TRUST160,0000 00For
SEI132,1540 00For
UNIFIED SERIES TRUST79,5640 00For
Prudential/PGIM60,4260 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
SEI Exchange Traded Funds43,3000 00For
JPMorgan35,4220 00For
Empower23,5460 00For
TARGET PORTFOLIO TRUST20,2000 00For
Vanguard19,9543 00For
Global X14,7190 00For
Zacks Trust11,7500 00For
RBB Fund Trust6,3010 00For
STERLING CAPITAL FUNDS5,6520 00For
New York Life4,2540 00For
NEW COVENANT FUNDS2,9150 00For
Venerable Variable Insurance Trust2,3900 00For
NYLIM VP FUNDS TRUST2,1740 00For
CLEARWATER INVESTMENT TRUST1,4000 00For
Nationwide1,3630 00For
Advisors' Inner Circle Fund III1650 00For
SARATOGA ADVANTAGE TRUST80 00For

10. Elect Director: Garen Bohlin

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 27,093,924AGAINST: 243,649
Details: description as filed, official tally, votes by 24 asset managers

Description as filed by funds: Election of directors to hold office until the 2027 Annual Meeting: Garen Bohlin

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Garen Bohlin”): 27,093,924 for, 243,649 against, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, Michael Donovan, John Freund, Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini was elected by the Company's shareholders as Directors to hold office until the 2027 Annual Meeting of Shareholders.”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 24 asset managers below reported 2,521,685 for, 166 against.

FOR
FOR: 2,521,685AGAINST: 166
Largest asset managers voting on “Election of directors to hold office until the 2027 Annual Meeting: Garen Bohlin” at Collegium Pharmaceutical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST1,408,0350 00For
Charles Schwab437,9570 00For
HUSSMAN INVESTMENT TRUST160,0000 00For
SEI132,1540 00For
UNIFIED SERIES TRUST79,5640 00For
Prudential/PGIM60,4260 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
SEI Exchange Traded Funds43,3000 00For
JPMorgan35,4220 00For
Empower23,5460 00For
TARGET PORTFOLIO TRUST20,2000 00For
Vanguard19,9551 00For
Global X14,7190 00For
Zacks Trust11,7500 00For
RBB Fund Trust6,3010 00For
STERLING CAPITAL FUNDS5,6520 00For
New York Life4,2540 00For
NEW COVENANT FUNDS2,9150 00For
Venerable Variable Insurance Trust2,3900 00For
NYLIM VP FUNDS TRUST2,1740 00For
CLEARWATER INVESTMENT TRUST1,4000 00For
Nationwide1,3630 00For
Advisors' Inner Circle Fund III0165 00Against
SARATOGA ADVANTAGE TRUST80 00For

11. Elect Director: Gino Santini

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 26,824,258AGAINST: 593,714
Details: description as filed, official tally, votes by 24 asset managers

Description as filed by funds: Election of directors to hold office until the 2027 Annual Meeting: Gino Santini

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Gino Santini”): 26,824,258 for, 593,714 against, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, Michael Donovan, John Freund, Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini was elected by the Company's shareholders as Directors to hold office until the 2027 Annual Meeting of Shareholders.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 24 asset managers below reported 2,515,257 for, 6,595 against.

FOR
FOR: 2,515,257AGAINST: 6,595
Largest asset managers voting on “Election of directors to hold office until the 2027 Annual Meeting: Gino Santini” at Collegium Pharmaceutical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST1,408,0350 00For
Charles Schwab437,9570 00For
HUSSMAN INVESTMENT TRUST160,0000 00For
SEI132,1540 00For
UNIFIED SERIES TRUST79,5640 00For
Prudential/PGIM60,4260 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
SEI Exchange Traded Funds43,3000 00For
JPMorgan35,4220 00For
Empower23,5460 00For
TARGET PORTFOLIO TRUST20,2000 00For
Vanguard19,9552 00For
Global X14,7190 00For
Zacks Trust11,7500 00For
RBB Fund Trust6,3010 00For
STERLING CAPITAL FUNDS5,6520 00For
New York Life04,254 00Against
NEW COVENANT FUNDS2,9150 00For
Venerable Variable Insurance Trust2,3900 00For
NYLIM VP FUNDS TRUST02,174 00Against
CLEARWATER INVESTMENT TRUST1,4000 00For
Nationwide1,3630 00For
Advisors' Inner Circle Fund III0165 00Against
SARATOGA ADVANTAGE TRUST80 00For

12. Elect Director: John Freund, M.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 26,907,371AGAINST: 510,601
Details: description as filed, official tally, votes by 24 asset managers

Description as filed by funds: Election of directors to hold office until the 2027 Annual Meeting: John Freund, M.D.

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: John Freund, M.D.”): 26,907,371 for, 510,601 against, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, Michael Donovan, John Freund, Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini was elected by the Company's shareholders as Directors to hold office until the 2027 Annual Meeting of Shareholders.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 24 asset managers below reported 2,521,685 for, 167 against.

FOR
FOR: 2,521,685AGAINST: 167
Largest asset managers voting on “Election of directors to hold office until the 2027 Annual Meeting: John Freund, M.D.” at Collegium Pharmaceutical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST1,408,0350 00For
Charles Schwab437,9570 00For
HUSSMAN INVESTMENT TRUST160,0000 00For
SEI132,1540 00For
UNIFIED SERIES TRUST79,5640 00For
Prudential/PGIM60,4260 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
SEI Exchange Traded Funds43,3000 00For
JPMorgan35,4220 00For
Empower23,5460 00For
TARGET PORTFOLIO TRUST20,2000 00For
Vanguard19,9552 00For
Global X14,7190 00For
Zacks Trust11,7500 00For
RBB Fund Trust6,3010 00For
STERLING CAPITAL FUNDS5,6520 00For
New York Life4,2540 00For
NEW COVENANT FUNDS2,9150 00For
Venerable Variable Insurance Trust2,3900 00For
NYLIM VP FUNDS TRUST2,1740 00For
CLEARWATER INVESTMENT TRUST1,4000 00For
Nationwide1,3630 00For
Advisors' Inner Circle Fund III0165 00Against
SARATOGA ADVANTAGE TRUST80 00For

13. Elect Director: Michael Donovan

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 27,383,194AGAINST: 35,519
Details: description as filed, official tally, votes by 24 asset managers

Description as filed by funds: Election of directors to hold office until the 2027 Annual Meeting: Michael Donovan

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Michael Donovan”): 27,383,194 for, 35,519 against, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, Michael Donovan, John Freund, Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini was elected by the Company's shareholders as Directors to hold office until the 2027 Annual Meeting of Shareholders.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 24 asset managers below reported 2,521,852 for.

FOR
FOR: 2,521,852
Largest asset managers voting on “Election of directors to hold office until the 2027 Annual Meeting: Michael Donovan” at Collegium Pharmaceutical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST1,408,0350 00For
Charles Schwab437,9570 00For
HUSSMAN INVESTMENT TRUST160,0000 00For
SEI132,1540 00For
UNIFIED SERIES TRUST79,5640 00For
Prudential/PGIM60,4260 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
SEI Exchange Traded Funds43,3000 00For
JPMorgan35,4220 00For
Empower23,5460 00For
TARGET PORTFOLIO TRUST20,2000 00For
Vanguard19,9570 00For
Global X14,7190 00For
Zacks Trust11,7500 00For
RBB Fund Trust6,3010 00For
STERLING CAPITAL FUNDS5,6520 00For
New York Life4,2540 00For
NEW COVENANT FUNDS2,9150 00For
Venerable Variable Insurance Trust2,3900 00For
NYLIM VP FUNDS TRUST2,1740 00For
CLEARWATER INVESTMENT TRUST1,4000 00For
Nationwide1,3630 00For
Advisors' Inner Circle Fund III1650 00For
SARATOGA ADVANTAGE TRUST80 00For

14. Elect Director: Nancy Lurker

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 27,379,677AGAINST: 39,738
Details: description as filed, official tally, votes by 24 asset managers

Description as filed by funds: Election of directors to hold office until the 2027 Annual Meeting: Nancy Lurker

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Nancy Lurker”): 27,379,677 for, 39,738 against, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, Michael Donovan, John Freund, Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini was elected by the Company's shareholders as Directors to hold office until the 2027 Annual Meeting of Shareholders.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 24 asset managers below reported 1,177,476 for.

FOR
FOR: 1,177,476
Largest asset managers voting on “Election of directors to hold office until the 2027 Annual Meeting: Nancy Lurker” at Collegium Pharmaceutical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab437,9570 00For
HUSSMAN INVESTMENT TRUST160,0000 00For
SEI132,1540 00For
UNIFIED SERIES TRUST79,5640 00For
MUTUAL FUND SERIES TRUST63,6590 00For
Prudential/PGIM60,4260 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
SEI Exchange Traded Funds43,3000 00For
JPMorgan35,4220 00For
Empower23,5460 00For
TARGET PORTFOLIO TRUST20,2000 00For
Vanguard19,9570 00For
Global X14,7190 00For
Zacks Trust11,7500 00For
RBB Fund Trust6,3010 00For
STERLING CAPITAL FUNDS5,6520 00For
New York Life4,2540 00For
NEW COVENANT FUNDS2,9150 00For
Venerable Variable Insurance Trust2,3900 00For
NYLIM VP FUNDS TRUST2,1740 00For
CLEARWATER INVESTMENT TRUST1,4000 00For
Nationwide1,3630 00For
Advisors' Inner Circle Fund III1650 00For
SARATOGA ADVANTAGE TRUST80 00For

15. Elect Director: Rita Balice-Gordon

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 25,890,238AGAINST: 1,343,456
Details: description as filed, official tally, votes by 24 asset managers

Description as filed by funds: Election of directors to hold office until the 2027 Annual Meeting: Rita Balice-Gordon, Ph.D.

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Rita Balice-Gordon”): 25,890,238 for, 1,343,456 against, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 24 asset managers below reported 2,267,821 for, 254,030 against, 1 abstained.

FOR
FOR: 2,267,821AGAINST: 254,030ABSTAIN: 1
Largest asset managers voting on “Election of directors to hold office until the 2027 Annual Meeting: Rita Balice-Gordon, Ph.D.” at Collegium Pharmaceutical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST1,408,0350 00For
Charles Schwab437,9570 00For
HUSSMAN INVESTMENT TRUST160,0000 00For
SEI0132,154 00Against
UNIFIED SERIES TRUST79,5640 00For
Prudential/PGIM60,4260 00For
ADVISORS' INNER CIRCLE FUND048,200 00Against
SEI Exchange Traded Funds043,300 00Against
JPMorgan35,4220 00For
Empower23,5460 00For
TARGET PORTFOLIO TRUST20,2000 00For
Vanguard15,2564,700 10Mixed
Global X014,719 00Against
Zacks Trust11,7500 00For
RBB Fund Trust6,3010 00For
STERLING CAPITAL FUNDS05,652 00Against
New York Life4,2540 00For
NEW COVENANT FUNDS02,915 00Against
Venerable Variable Insurance Trust02,390 00Against
NYLIM VP FUNDS TRUST2,1740 00For
CLEARWATER INVESTMENT TRUST1,4000 00For
Nationwide1,3630 00For
Advisors' Inner Circle Fund III1650 00For
SARATOGA ADVANTAGE TRUST80 00For

16. Elect Director: Vikram Karnani

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 27,243,959AGAINST: 173,863
Details: description as filed, official tally, votes by 24 asset managers

Description as filed by funds: Election of directors to hold office until the 2027 Annual Meeting: Vikram Karnani

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Vikram Karnani”): 27,243,959 for, 173,863 against, per its Form 8-K filed May 15, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of Rita Balice-Gordon, Garen Bohlin, Michael Donovan, John Freund, Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini was elected by the Company's shareholders as Directors to hold office until the 2027 Annual Meeting of Shareholders.”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 24 asset managers below reported 2,521,851 for, 1 against.

FOR
FOR: 2,521,851AGAINST: 1
Largest asset managers voting on “Election of directors to hold office until the 2027 Annual Meeting: Vikram Karnani” at Collegium Pharmaceutical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
MUTUAL FUND SERIES TRUST1,408,0350 00For
Charles Schwab437,9570 00For
HUSSMAN INVESTMENT TRUST160,0000 00For
SEI132,1540 00For
UNIFIED SERIES TRUST79,5640 00For
Prudential/PGIM60,4260 00For
ADVISORS' INNER CIRCLE FUND48,2000 00For
SEI Exchange Traded Funds43,3000 00For
JPMorgan35,4220 00For
Empower23,5460 00For
TARGET PORTFOLIO TRUST20,2000 00For
Vanguard19,9561 00For
Global X14,7190 00For
Zacks Trust11,7500 00For
RBB Fund Trust6,3010 00For
STERLING CAPITAL FUNDS5,6520 00For
New York Life4,2540 00For
NEW COVENANT FUNDS2,9150 00For
Venerable Variable Insurance Trust2,3900 00For
NYLIM VP FUNDS TRUST2,1740 00For
CLEARWATER INVESTMENT TRUST1,4000 00For
Nationwide1,3630 00For
Advisors' Inner Circle Fund III1650 00For
SARATOGA ADVANTAGE TRUST80 00For

17. 2. Approval of, on an advisory basis, the compensation of the Company's named executive officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 8 wordings of this item as funds reported it.

96% Approved · of votes cast

FOR 96%
FOR: 26,313,792AGAINST: 1,100,723
Details: description as filed, official tally, votes by 333 asset managers

Description as filed by funds: Approval of, on an advisory basis, the compensation of the Company's named executive officers

Collegium Pharmaceutical, Inc.’s own tally for this item (“2. Approval of, on an advisory basis, the compensation of the Company's named executive officers”): 26,313,792 for, 1,100,723 against — passed, per its Form 8-K filed May 15, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “On an advisory basis, the Company's shareholders approved the compensation of the Company's named executive officers.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 106 asset managers voting on “Approval of, on an advisory basis, the compensation of the Company's named executive officers” at Collegium Pharmaceutical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock2,442,9090 00For
Vanguard2,104,8603 00For
Capitol Series Trust1,430,7080 00For
MUTUAL FUND SERIES TRUST1,408,0350 00For
MFS1,196,5830 00For
Invesco1,064,0250 00For
Fidelity802,5870 00For
State Street647,9910 00For
Principal618,8380 00For
Charles Schwab437,9570 00For
American Century0437,768 00Against
Royce267,3830 00For
Victory Capital262,4020 00For
Pacer Funds Trust256,3650 00For
RBB FUND, INC.207,3190 00For
Dimensional204,5660 00For
Bridge Builder Trust171,8000 00For
World Funds Trust165,2080 00For
Janus Detroit Street Trust161,1180 00For
Empower160,0540 00For
THIRD AVENUE TRUST154,8240 00For
SEI132,1540 00For
OLD WESTBURY FUNDS INC97,6550 00For
MassMutual81,4000 00For
UNIFIED SERIES TRUST079,564 00Against

Fund voting reports, all 106 managers: 16,028,105 for, 595,500 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 252 asset managers voting on “Approval of, on an advisory basis, the compensation of the Company's named executive officers” at Collegium Pharmaceutical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Janus Henderson2,610,5720 00For
FULLER & THALER ASSET MANAGEMENT, INC.1,494,0570 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/1,369,5090 00For
Invesco1,267,8870 00For
BlackRock1,234,1860 00For
Rubric Capital Management LP914,3470 00For
PRINCIPAL GLOBAL INVESTORS895,1140 00For
GEODE CAPITAL MANAGEMENT, LLC819,3700 00For
State Street683,0151,075 00For
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP561,6960 00For
Victory Capital549,9400 00For
Charles Schwab494,9220 00For
American Century0460,728 00Against
Renaissance400,9010 00For
Loomis Sayles347,8570 00For
Vanguard270,9290 00For
Northern Trust250,8730 00For
SEI211,1610 00For
EMERALD ADVISERS, LLC196,9530 00For
BESSEMER INVESTMENT MANAGEMENT LLC195,3100 00For
Hillsdale Investment Management Inc.184,3000 00For
MARSHALL WACE, LLP179,2360 00For
MELLON INVESTMENTS Corp166,9680 00For
DE Shaw156,6540 00For
PUBLIC SECTOR PENSION INVESTMENT BOARD141,2510 00For

Institutional-manager reports, all 252 managers: 18,284,531 for, 800,266 against, 701 not voted. Showing the 25 largest; see all in the interactive database.

18. 3. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.1% Approved · of votes cast

FOR 99.1%
FOR: 28,953,181AGAINST: 252,815
Details: description as filed, official tally, votes by 108 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026

Collegium Pharmaceutical, Inc.’s own tally for this item (“3. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 28,953,181 for, 252,815 against — passed, per its Form 8-K filed May 15, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3: Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 108 asset managers below reported 16,609,415 for, 16,103 against.

FOR
FOR: 16,609,415AGAINST: 16,103
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUN” at Collegium Pharmaceutical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock2,442,9090 00For
Vanguard2,104,8630 00For
Capitol Series Trust1,430,7080 00For
MUTUAL FUND SERIES TRUST1,408,0350 00For
MFS1,196,5830 00For
Invesco1,064,0250 00For
Fidelity802,5870 00For
State Street647,92566 00For
Principal618,8380 00For
Charles Schwab437,9570 00For
American Century437,7680 00For
Royce267,3830 00For
Victory Capital262,4020 00For
Pacer Funds Trust256,3650 00For
RBB FUND, INC.207,3190 00For
Dimensional204,5660 00For
Bridge Builder Trust171,8000 00For
World Funds Trust165,2080 00For
Janus Detroit Street Trust161,1180 00For
Empower160,0540 00For
THIRD AVENUE TRUST154,8240 00For
SEI132,1540 00For
OLD WESTBURY FUNDS INC97,6550 00For
MassMutual81,4000 00For
UNIFIED SERIES TRUST79,5640 00For

Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.

Largest Collegium Pharmaceutical, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 32,433,779 shares outstanding at the time of that meeting.

Fund voting reports: top Collegium Pharmaceutical, Inc. shareholders by shares voted on “Approval of, on an advisory basis, the compensation of the Company's named executive officers”, 2025-2026
#Asset manager % of shares outstanding
1BlackRock 7.53%
2Vanguard 6.49%
3Capitol Series Trust 4.41%
4MUTUAL FUND SERIES TRUST 4.34%
5MFS 3.69%
6Invesco 3.28%
7Fidelity 2.47%
8State Street 2.00%
9Principal 1.91%
10Charles Schwab 1.35%
Institutional-manager reports: top Collegium Pharmaceutical, Inc. shareholders by shares voted on “Approval of, on an advisory basis, the compensation of the Company's named executive officers”, 2025-2026
#Asset manager % of shares outstanding
1Janus Henderson 8.05%
2FULLER & THALER ASSET MANAGEMENT, INC. 4.61%
3MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 4.22%
4Invesco 3.91%
5BlackRock 3.81%
6Rubric Capital Management LP 2.82%
7PRINCIPAL GLOBAL INVESTORS 2.76%
8GEODE CAPITAL MANAGEMENT, LLC 2.53%
9State Street 2.11%
10ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.73%

Reported Collegium Pharmaceutical, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Collegium Pharmaceutical, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
BlackRock 15.83% 13F
Vanguard Group 6.96% 13F
JANUS HENDERSON GROUP PLC 5.63% 13G
Integrated Core Strategies (US) LLC 5.45% 13G
Fuller & Thaler Asset Management, Inc. 5.03% 13G
PRINCIPAL GLOBAL INVESTORS 5.03% 13G
Invesco 4.91% 13F
Renaissance Technologies 4.53% 13F
State Street 4.39% 13F
Eventide Asset Management, LLC 4.39% 13G

Percentages above are of 32,433,779 shares outstanding, as reported by Collegium Pharmaceutical, Inc. on its Form 10-Q dated April 30, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Collegium Pharmaceutical, Inc.’s 10-Q dated April 30, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At Collegium Pharmaceutical, Inc.'s shareholder meeting held May 14, 2026, in the 2025-2026 proxy season, 333 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,605 separate fund positions. Their filings are grouped here into 18 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval of, on an advisory basis, the compensation of the Company's named executive officers — Collegium Pharmaceutical, Inc.'s filing reports the proposal as approved, with 96% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Collegium Pharmaceutical, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 15, 2026.

Collegium Pharmaceutical, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.